| scholarly article | Q13442814 |
| P2093 | author name string | Hang Lee | |
| Benjamin Z Leder | |||
| Maria P Henao | |||
| Sherri-Ann M Burnett-Bowie | |||
| Melissa E Dere | |||
| P2860 | cites work | Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells | Q45238632 |
| Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. | Q46680438 | ||
| Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D. | Q46761922 | ||
| Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men. | Q46849855 | ||
| Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism | Q46871114 | ||
| Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells | Q46970328 | ||
| Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic Patients | Q57692114 | ||
| Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men | Q79298180 | ||
| Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women | Q79995263 | ||
| Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism | Q81251002 | ||
| Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 | ||
| FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis | Q24319751 | ||
| Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia | Q24623628 | ||
| The parathyroid is a target organ for FGF23 in rats | Q28572613 | ||
| Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo | Q28572995 | ||
| Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men. | Q31831133 | ||
| Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers | Q33974129 | ||
| Evidence for a bone-kidney axis regulating phosphate homeostasis | Q35679294 | ||
| Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men | Q36153795 | ||
| Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD | Q36667209 | ||
| Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice | Q44142771 | ||
| Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia | Q44203982 | ||
| Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunte | Q44392870 | ||
| Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia | Q44414604 | ||
| Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism | Q44974453 | ||
| FGF-23 is elevated by chronic hyperphosphatemia | Q45050609 | ||
| Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism | Q45184497 | ||
| Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. | Q45197408 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1681-1685 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men. | |
| P478 | volume | 24 |
| Q35692471 | (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers |
| Q41889533 | 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro. |
| Q35783146 | A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells |
| Q33894092 | A physiologic-based approach to the evaluation of a patient with hyperphosphatemia |
| Q50785234 | Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels. |
| Q47989110 | Biology of Fibroblast Growth Factor 23: From Physiology to Pathology |
| Q37331084 | Calcium regulates FGF-23 expression in bone |
| Q27024043 | Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease |
| Q85025638 | Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation |
| Q54295582 | Downregulation of renal type IIa sodium-dependent phosphate cotransporter during lipopolysaccharide-induced acute inflammation. |
| Q28085476 | Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity |
| Q35682152 | Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism |
| Q33851227 | Effects of Different 1-34 Parathyroid Hormone Dosages on Fibroblast Growth Factor-23 Secretion in Human Bone Marrow Cells following Osteogenic Differentiation |
| Q89821664 | Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis |
| Q35129687 | FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. |
| Q38031216 | FGF-23: the rise of a novel cardiovascular risk marker in CKD. |
| Q90624325 | FGF23 and Associated Disorders of Phosphate Wasting |
| Q37996937 | FGF23 and PTH--double agents at the heart of CKD. |
| Q37148561 | Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice. |
| Q34280125 | Fibroblast growth factor 23 in acute kidney injury |
| Q35664606 | Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study |
| Q56627579 | Hypophosphatemic rickets |
| Q36911899 | Insights from genetic disorders of phosphate homeostasis |
| Q57152961 | Interactions of Phosphate Metabolism With Serious Injury, Including Burns |
| Q58701703 | Intestinal Phosphorus Absorption in Chronic Kidney Disease |
| Q33570120 | Lack of FGF23 response to acute changes in serum calcium and PTH in humans |
| Q59797831 | Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol |
| Q46101921 | Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription |
| Q41865104 | Phosphate metabolism and vitamin D. |
| Q37154351 | Plasma FGF23 levels increase rapidly after acute kidney injury. |
| Q36649088 | Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. |
| Q36492263 | Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide |
| Q34568797 | Renal phosphate wasting in the absence of adenylyl cyclase 6 |
| Q90102237 | Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters |
| Q38571195 | The PTH-Vitamin D-FGF23 axis |
| Q33835743 | The use of fibroblast growth factor 23 testing in patients with kidney disease |
Search more.